ArticlePPAR research2010

Is there a biological basis for treatment of fibrodysplasia ossificans progressiva with rosiglitazone? Potential benefits and undesired effects.

Renata Bocciardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.